How effective are antioxidant supplements in obesity and diabetes?

Daniyal Abdali, Sue E Samson, Ashok Kumar Grover, Daniyal Abdali, Sue E Samson, Ashok Kumar Grover

Abstract

Obesity is a central health issue due to its epidemic prevalence and its association with type 2 diabetes and other comorbidities. Obesity is not just being overweight. It is a metabolic disorder due to the accumulation of excess dietary calories into visceral fat and the release of high concentrations of free fatty acids into various organs. It represents a state of chronic oxidative stress and low-grade inflammation whose intermediary molecules may include leptin, adiponectin and cytokines. It may progress to hyperglycemia, leading to type 2 diabetes. Whether or not dietary antioxidant supplements are useful in the management of obesity and type 2 diabetes is discussed in this review. Only the benefits for obesity and diabetes are examined here. Other health benefits of antioxidants are not considered. There are difficulties in comparing studies in this field because they differ in the time frame, participants' ethnicity, administration of antioxidant supplements, and even in how obesity was measured. However, the literature presents reasonable evidence for marginal benefits of supplementation with zinc, lipoic acid, carnitine, cinnamon, green tea, and possibly vitamin C plus E, although the evidence is much weaker for omega-3 polyunsaturated fatty acids, coenzyme Q10, green coffee, resveratrol, or lycopene. Overall, antioxidant supplements are not a panacea to compensate for a fast-food and video-game way of living, but antioxidant-rich foods are recommended as part of the lifestyle. Such antioxidant foods are commonly available.

Figures

Fig. 1
Fig. 1
Pathways from excess calorie consumption to obesity and diabetes. Excess calories lead to blockade of the steps in the pathways, as shown by ‘x’.

References

    1. Behbehani K. Kuwait National Programme for Healthy Living: first 5-year plan (2013–2017). Med Princ Pract. 2014;23(suppl 1):32–42.
    1. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–867.
    1. World Health Organization Obesity: preventing and managing the global epidemic. 2000.
    1. Bruckert E. Abdominal obesity: a health threat (in French) Presse Med. 2008;37:1407–1414.
    1. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881–887.
    1. Schelbert KB. Comorbidities of obesity. Prim Care. 2009;36:271–285.
    1. Al Lawati JA, Barakat NM, Al Lawati AM, et al. Optimal cut-points for body mass index, waist circumference and waist-to-hip ratio using the Framingham coronary heart disease risk score in an Arab population of the Middle East. Diab Vasc Dis Res. 2008;5:304–309.
    1. Brennan DD, Whelan PF, Robinson K, et al. Rapid automated measurement of body fat distribution from whole-body MRI. AJR Am J Roentgenol. 2005;185:418–423.
    1. Hofker M, Wijmenga C. A supersized list of obesity genes. Nat Genet. 2009;41:139–140.
    1. Wood IS, Trayhurn P. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr. 2003;89:3–9.
    1. Foley K, Boguslavsky S, Klip A. Endocytosis, recycling, and regulated exocytosis of glucose transporter 4. Biochemistry. 2011;50:3048–3061.
    1. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005;115:911–919.
    1. Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004;15:2792–2800.
    1. Walia M, Kwan CY, Grover AK. Effects of free radicals on coronary artery. Med Princ Pract. 2003;12:1–9.
    1. Fridovich I. Oxygen: how do we stand it? Med Princ Pract. 2013;22:131–137.
    1. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107:1058–1070.
    1. Rudich A, Kanety H, Bashan N. Adipose stress-sensing kinases: linking obesity to malfunction. Trends Endocrinol Metab. 2007;18:291–299.
    1. Jones DP. Redefining oxidative stress. Antioxid Redox Signal. 2006;8:1865–1879.
    1. Forman HJ, Davies KJ, Ursini F. How do nutritional antioxidants really work: nucleophilic tone and para-hormesis versus free radical scavenging in vivo. Free Radic Biol Med. 2014;66:24–35.
    1. Liochev SI. Free radicals: how do we stand them? Anaerobic and aerobic free radical (chain) reactions involved in the use of fluorogenic probes and in biological systems. Med Princ Pract. 2014;23:195–203.
    1. Vincent HK, Innes KE, Vincent KR. Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes Obes Metab. 2007;9:813–839.
    1. Kitabchi AE, McDaniel KA, Wan JY, et al. Effects of high-protein versus high-carbohydrate diets on markers of beta-cell function, oxidative stress, lipid peroxidation, proinflammatory cytokines, and adipokines in obese, premenopausal women without diabetes: a randomized controlled trial. Diabetes Care. 2013;36:1919–1925.
    1. Esteghamati A, Eskandari D, Mirmiranpour H, et al. Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: a randomized clinical trial. Clin Nutr. 2013;32:179–185.
    1. Golbidi S, Badran M, Laher I. Diabetes and alpha lipoic acid. Front Pharmacol. 2011;2:69.
    1. Niki E. Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence. Free Radic Biol Med. 2014;66:3–12.
    1. Harding AH, Wareham NJ, Bingham SA, et al. Plasma vitamin C level, fruit and vegetable consumption, and the risk of new-onset type 2 diabetes mellitus: the European prospective investigation of cancer – Norfolk prospective study. Arch Intern Med. 2008;168:1493–1499.
    1. Rafighi Z, Shiva A, Arab S, Mohd YR. Association of dietary vitamin C and E intake and antioxidant enzymes in type 2 diabetes mellitus patients. Glob J Health Sci. 2013;5:183–187.
    1. Naziroglu M, Simsek M, Simsek H, et al. The effects of hormone replacement therapy combined with vitamins C and E on antioxidants levels and lipid profiles in postmenopausal women with type 2 diabetes. Clin Chim Acta. 2004;344:63–71.
    1. Kataja-Tuomola MK, Kontto JP, Mannisto S, et al. Intake of antioxidants and risk of type 2 diabetes in a cohort of male smokers. Eur J Clin Nutr. 2011;65:590–597.
    1. Ristow M, Zarse K, Oberbach A, et al. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci USA. 2009;106:8665–8670.
    1. Rotilio G, Calabrese L, Bossa F, et al. Properties of the apoprotein and role of copper and zinc in protein conformation and enzyme activity of bovine superoxide dismutase. Biochemistry. 1972;11:2182–2187.
    1. Vashum KP, McEvoy M, Shi Z, et al. Is dietary zinc protective for type 2 diabetes? Results from the Australian longitudinal study on women's health. BMC Endocr Disord. 2013;13:40.
    1. Hussain SA, Khadim HM, Khalaf BH, et al. Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin. Saudi Med J. 2006;27:1483–1488.
    1. Gunasekara P, Hettiarachchi M, Liyanage C, et al. Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetes. Diabetes Metab Syndr Obes. 2011;4:53–60.
    1. Roussel AM, Kerkeni A, Zouari N, et al. Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J Am Coll Nutr. 2003;22:316–321.
    1. Partida-Hernandez G, Arreola F, Fenton B, et al. Effect of zinc replacement on lipids and lipoproteins in type 2 diabetic patients. Biomed Pharmacother. 2006;60:161–168.
    1. Seet RC, Lee CY, Lim EC, et al. Oral zinc supplementation does not improve oxidative stress or vascular function in patients with type 2 diabetes with normal zinc levels. Atherosclerosis. 2011;219:231–239.
    1. Parham M, Amini M, Aminorroaya A, et al. Effect of zinc supplementation on microalbuminuria in patients with type 2 diabetes: a double-blind, randomized, placebo-controlled, cross-over trial. Rev Diabet Stud. 2008;5:102–109.
    1. Jayawardena R, Ranasinghe P, Galappatthy P, et al. Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr. 2012;4:13.
    1. Radke GA, Ono K, Ravindran S, et al. Critical role of a lipoyl cofactor of the dihydrolipoyl acetyltransferase in the binding and enhanced function of the pyruvate dehydrogenase kinase. Biochem Biophys Res Commun. 1993;190:982–991.
    1. Wagenknecht T, Frank J. Localization of lipoyl-bearing domains in the alpha-ketoglutarate dehydrogenase multienzyme complex. Biochemistry. 1984;23:3383–3389.
    1. Biewenga GP, Haenen GR, Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol. 1997;29:315–331.
    1. Carbonelli MG, Di Renzo L, Bigioni M, et al. α-Lipoic acid supplementation: a tool for obesity therapy? Curr Pharm Des. 2010;16:840–846.
    1. Ansar H, Mazloom Z, Kazemi F, et al. Effect of α-lipoic acid on blood glucose, insulin resistance and glutathione peroxidase of type 2 diabetic patients. Saudi Med J. 2011;32:584–588.
    1. Kamenova P. Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of α-lipoic acid. Hormones (Athens) 2006;5:251–258.
    1. McNeilly AM, Davison GW, Murphy MH, et al. Effect of α-lipoic acid and exercise training on cardiovascular disease risk in obesity with impaired glucose tolerance. Lipids Health Dis. 2011;10:217.
    1. Koh EH, Lee WJ, Lee SA, et al. Effects of α-lipoic acid on body weight in obese subjects. Am J Med. 2011;124:85–88.
    1. Zhang Y, Han P, Wu N, et al. Amelioration of lipid abnormalities by α-lipoic acid through antioxidative and anti-inflammatory effects. Obesity (Silver Spring) 2011;19:1647–1653.
    1. Gianturco V, Bellomo A, D'Ottavio E, et al. Impact of therapy with α-lipoic acid (ALA) on the oxidative stress in the controlled NIDDM: a possible preventive way against the organ dysfunction? Arch Gerontol Geriatr. 2009;49(suppl 1):129–133.
    1. Xiao C, Giacca A, Lewis GF. Short-term oral α-lipoic acid does not prevent lipid induced dysregulation of glucose homeostasis in obese and overweight nondiabetic men. Am J Physiol Endocrinol Metab. 2011;301:E736–E741.
    1. Normann PT, Flatmark T. Long-chain acyl-CoA synthetase and ‘outer’ carnitine long-chain acyltransferase activities of intact brown adipose tissue mitochondria. Biochim Biophys Acta. 1978;530:461–473.
    1. Derosa G, Maffioli P, Ferrari I, et al. Comparison between orlistat plus L-carnitine and orlistat alone on inflammation parameters in obese diabetic patients. Fundam Clin Pharmacol. 2011;25:642–651.
    1. Derosa G, Maffioli P, Salvadeo SA, et al. Sibutramine and L-carnitine compared to sibutramine alone on insulin resistance in diabetic patients. Intern Med. 2010;49:1717–1725.
    1. Malaguarnera M, Vacante M, Motta M, et al. Effect of L-carnitine on the size of low-density lipoprotein particles in type 2 diabetes mellitus patients treated with simvastatin. Metabolism. 2009;58:1618–1623.
    1. Galvano F, Li VG, Malaguarnera M, et al. Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in type 2 diabetes mellitus. Expert Opin Pharmacother. 2009;10:1875–1882.
    1. Vidal-Casariego A, Burgos-Pelaez R, Martinez-Faedo C, et al. Metabolic effects of L-carnitine on type 2 diabetes mellitus: systematic review and meta-analysis. Exp Clin Endocrinol Diabetes. 2013;121:234–238.
    1. Lands B. Historical perspectives on the impact of n-3 and n-6 nutrients on health. Prog Lipid Res. 2014;55:17–29.
    1. Munro IA, Garg ML. Dietary supplementation with long chain omega-3 polyunsaturated fatty acids and weight loss in obese adults. Obes Res Clin Pract. 2013;7:e173–e181.
    1. Munro IA, Garg ML. Dietary supplementation with n-3 PUFA does not promote weight loss when combined with a very-low-energy diet. Br J Nutr. 2012;108:1466–1474.
    1. Summers LK, Fielding BA, Bradshaw HA, et al. Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia. 2002;45:369–377.
    1. Crane FL. Biochemical functions of coenzyme Q10. J Am Coll Nutr. 2001;20:591–598.
    1. Lee YJ, Cho WJ, Kim JK, et al. Effects of coenzyme Q10 on arterial stiffness, metabolic parameters, and fatigue in obese subjects: a double-blind randomized controlled study. J Med Food. 2011;14:386–390.
    1. Kolahdouz MR, Hosseinzadeh-Attar MJ, Eshraghian MR, et al. The effect of coenzyme Q10 supplementation on metabolic status of type 2 diabetic patients. Minerva Gastroenterol Dietol. 2013;59:231–236.
    1. Hamilton SJ, Chew GT, Watts GF. Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients. Diabetes Care. 2009;32:810–812.
    1. Sohet FM, Delzenne NM. Is there a place for coenzyme Q in the management of metabolic disorders associated with obesity? Nutr Rev. 2012;70:631–641.
    1. Gu L, Kelm MA, Hammerstone JF, et al. Liquid chromatographic/electrospray ionization mass spectrometric studies of proanthocyanidins in foods. J Mass Spectrom. 2003;38:1272–1280.
    1. Khan A, Safdar M, Ali Khan MM, et al. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 2003;26:3215–3218.
    1. Mang B, Wolters M, Schmitt B, et al. Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2. Eur J Clin Invest. 2006;36:340–344.
    1. Lu T, Sheng H, Wu J, et al. Cinnamon extract improves fasting blood glucose and glycosylated hemoglobin level in Chinese patients with type 2 diabetes. Nutr Res. 2012;32:408–412.
    1. Roussel AM, Hininger I, Benaraba R, et al. Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese. J Am Coll Nutr. 2009;28:16–21.
    1. Crawford P. Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial. J Am Board Fam Med. 2009;22:507–512.
    1. Vanschoonbeek K, Thomassen BJ, Senden JM, et al. Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients. J Nutr. 2006;136:977–980.
    1. Blevins SM, Leyva MJ, Brown J, et al. Effect of cinnamon on glucose and lipid levels in non-insulin-dependent type 2 diabetes. Diabetes Care. 2007;30:2236–2237.
    1. Woehrlin F, Fry H, Abraham K, et al. Quantification of flavoring constituents in cinnamon: high variation of coumarin in cassia bark from the German retail market and in authentic samples from Indonesia. J Agric Food Chem. 2010;58:10568–10575.
    1. Ranasinghe P, Jayawardana R, Galappaththy P, et al. Efficacy and safety of ‘true’ cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis. Diabet Med. 2012;29:1480–1492.
    1. All about green tea: major components and health benefits of green tea. ITO EN, 2014.
    1. Auvichayapat P, Prapochanung M, Tunkamnerdthai O, et al. Effectiveness of green tea on weight reduction in obese Thais: a randomized, controlled trial. Physiol Behav. 2008;93:486–491.
    1. Chantre P, Lairon D. Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Phytomedicine. 2002;9:3–8.
    1. Hsu CH, Liao YL, Lin SC, et al. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Altern Med Rev. 2011;16:157–163.
    1. Westerterp-Plantenga MS, Lejeune MP, Kovacs EM. Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Obes Res. 2005;13:1195–1204.
    1. Ammon HP. Biochemical mechanism of caffeine tolerance. Arch Pharm (Weinheim) 1991;324:261–267.
    1. Kang C, Lee H, Jung ES, et al. Saffron (Crocus sativus L.) increases glucose uptake and insulin sensitivity in muscle cells via multipathway mechanisms. Food Chem. 2012;135:2350–2358.
    1. Vinson JA, Burnham BR, Nagendran MV. Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects. Diabetes Metab Syndr Obes. 2012;5:21–27.
    1. Onakpoya I, Terry R, Ernst E. The use of green coffee extract as a weight loss supplement: a systematic review and meta-analysis of randomised clinical trials. Gastroenterol Res Pract. 2011;2011:382852.
    1. Mancuso C, Santangelo R. Ferulic acid: pharmacological and toxicological aspects. Food Chem Toxicol. 2014;65:185–195.
    1. Karasawa K, Uzuhashi Y, Hirota M, et al. A matured fruit extract of date palm tree (Phoenix dactylifera L.) stimulates the cellular immune system in mice. J Agric Food Chem. 2011;59:11287–11293.
    1. Timmers S, Hesselink MK, Schrauwen P. Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits? Ann NY Acad Sci. 2013;1290:83–89.
    1. Brasnyo P, Molnar GA, Mohas M, et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr. 2011;106:383–389.
    1. Bhatt JK, Thomas S, Nanjan MJ. Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr Res. 2012;32:537–541.
    1. Crandall JP, Oram V, Trandafirescu G, et al. Pilot study of resveratrol in older adults with impaired glucose tolerance. J Gerontol A Biol Sci Med Sci. 2012;67:1307–1312.
    1. Poulsen MM, Vestergaard PF, Clasen BF, et al. High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes. 2013;62:1186–1195.
    1. Yoshino J, Conte C, Fontana L, et al. Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metab. 2012;16:658–664.
    1. Friedman M. Anticarcinogenic, cardioprotective, and other health benefits of tomato compounds lycopene, α-tomatine, and tomatidine in pure form and in fresh and processed tomatoes. J Agric Food Chem. 2013;61:9534–9550.
    1. Coyne T, Ibiebele TI, Baade PD, et al. Diabetes mellitus and serum carotenoids: findings of a population-based study in Queensland, Australia. Am J Clin Nutr. 2005;82:685–693.
    1. Ghavipour M, Saedisomeolia A, Djalali M, et al. Tomato juice consumption reduces systemic inflammation in overweight and obese females. Br J Nutr. 2013;109:2031–2035.
    1. Upritchard JE, Sutherland WH, Mann JI. Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care. 2000;23:733–738.
    1. Health Canada Canadian Nutrient File.
    1. Linus Pauling Institute at Oregon State University Micronutrient Information Center. 2014.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi